20α-Dihydrodydrogesterone
20α-Dihydrodydrogesterone is a progestogen that is a metabolite of dydrogesterone, a synthetic progesterone derivative. It is formed in the body after the administration of dydrogesterone, a medication used in a variety of gynecological disorders and in hormone therapy for menopausal symptoms. This compound plays a significant role in the pharmacodynamics of dydrogesterone, contributing to its progestogenic effects.
Chemistry[edit | edit source]
20α-Dihydrodydrogesterone belongs to the class of steroids, specifically within the group of progestogens. It is characterized by its chemical structure, which includes modifications from the natural progesterone molecule, enhancing its metabolic stability and progestogenic potency. The conversion from dydrogesterone to 20α-Dihydrodydrogesterone involves the reduction of a double bond in the A-ring of the steroid nucleus.
Pharmacology[edit | edit source]
Mechanism of Action[edit | edit source]
As a metabolite of dydrogesterone, 20α-Dihydrodydrogesterone contributes to the overall progestogenic activity of the parent drug. It exerts its effects by binding to and activating the progesterone receptor (PR) in target tissues, which include the endometrium, breast tissue, and the central nervous system. This activation leads to the transcription of genes that are responsible for the maintenance of pregnancy and the regulation of the menstrual cycle.
Pharmacokinetics[edit | edit source]
Following oral administration of dydrogesterone, it is rapidly metabolized in the liver to form 20α-Dihydrodydrogesterone among other metabolites. This metabolite, like its parent compound, is subject to further metabolic processes before being excreted.
Clinical Uses[edit | edit source]
20α-Dihydrodydrogesterone, through its parent compound dydrogesterone, is used in the treatment of a range of conditions that require progestogenic support. These include endometriosis, amenorrhea, and abnormal uterine bleeding. It is also used in hormone replacement therapy (HRT) for menopausal symptoms, in combination with estrogen.
Safety and Tolerability[edit | edit source]
The safety profile of 20α-Dihydrodydrogesterone is closely related to that of dydrogesterone. Generally, dydrogesterone and its metabolites are well tolerated, with adverse effects being rare and mostly mild. As with all medications, monitoring by a healthcare provider is essential to manage any potential side effects or interactions with other drugs.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD